BVS

NASDAQStock

Bioventus Inc.

$8.64+0.04 (+0.52%)

52-Week Range

$6.14

$9.93

Key Stats

Market Cap

579.0M

P/E Ratio

72.04

Dividend Yield

—

Beta

0.72

Volume

181.9K

Avg Volume

396.1K

Performance

+3.99%

+14.67%

+25.73%

YTD

+19.28%

-12.24%

+505.63%

-39.65%

Price Chart

ETF Exposure

BVS is held by 56 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	52	$565	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	1,879	$20K	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	9	$97	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	1,070,307	$8.5M	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	5,629	$60K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	485	$5K	$1.29B	0.17%

PreviousPage 2 of 2

About BVS ETF Exposure

Bioventus Inc. (BVS) is held by 56 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 579.0M, BVS is a widely held institutional stock. The stock currently trades at $8.64. Investors can gain exposure to BVS through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold BVS, sorted by portfolio weight.